ALCLS.PA PAR
Cellectis S.A.
1W: +0.0%
1M: -57.6%
3M: -54.2%
YTD: -63.0%
1Y: -45.4%
3Y: -29.0%
5Y: -89.4%
€1.25 ($1.41)
-0.04 (-2.79%)
Weekly Expected Move ±24.6%
€1
€1
€1
€2
€2
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$76M
+82.9% ▲
5Y CAGR: +0.5%
Gross Profit
$55M
+32.6% ▲
5Y CAGR: +7.9%
Operating Income
-$42M
+29.5% ▲
Net Income
-$70M
-91.4% ▼
EPS (Diluted)
$-0.70
-70.7% ▼
EBITDA
-$21M
-123.2% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $74M | $19M | $755K | $42M | $76M |
| YoY Growth | +0.0% | -74.1% | -96.1% | +5397.5% | +82.9% |
| Cost of Revenue | $36M | $2M | $737K | $9M | $21M |
| Gross Profit | $38M | $17M | $18K | $42M | $55M |
| Gross Margin | 50.9% | 90.8% | 2.4% | 100.0% | 72.5% |
| R&D Expenses | $87M | $98M | $88M | $91M | $97M |
| SG&A Expenses | $44M | $17M | $15M | $18M | $21M |
| Operating Expenses | $123M | $107M | $97M | $101M | $97M |
| Operating Income | -$85M | -$90M | -$97M | -$60M | -$42M |
| Operating Margin | -115.5% | -467.7% | -12887.7% | -143.5% | -55.3% |
| Interest Expense | $4M | $16M | $5M | $7M | $8M |
| Income Before Tax | -$97M | -$99M | -$116M | -$37M | -$78M |
| Tax Expense | -$11M | $87K | $371K | $0 | -$7M |
| Net Income | -$86M | -$99M | -$101M | -$37M | -$70M |
| Net Margin | -116.7% | -514.8% | -13385.3% | -88.6% | -92.7% |
| EPS (Diluted) | $-1.93 | $-2.17 | $-1.92 | $-0.41 | $-0.70 |
| EBITDA | -$85M | -$76M | -$93M | -$9M | -$21M |
| Shares Outstanding | 45M | 46M | 57M | 90M | 100M |